{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:22:59Z","timestamp":1772731379474,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clml.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T02:51:56Z","timestamp":1649386316000},"page":"e745-e750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes"],"prefix":"10.1016","volume":"22","author":[{"given":"Pierluigi","family":"Masciopinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Bellitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Arcuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Battisti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Cazzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommasina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena Emanuela","family":"Laddaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Maiorano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ingravallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-1665","authenticated-orcid":false,"given":"Francesco","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2022.04.002_bib0001","doi-asserted-by":"crossref","unstructured":"Swerdlow SH, Campo E, Pileri SA, et\u00a0al. Review series the updated WHO classification of hematological malignancies. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90. doi:10.1182\/blood-2016-01-643569. Epub 2016 Mar 15. PMID: 26980727; PMCID: PMC4874220.","DOI":"10.1182\/blood-2016-01-643569"},{"issue":"8","key":"10.1016\/j.clml.2022.04.002_bib0002","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","article-title":"Nonhepatosplenic Gd T-cell lymphomas represent a spectrum of aggressive cytotoxic t-cell lymphomas with a mainly extranodal presentation","volume":"35","author":"Garcia-Herrera","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2022.04.002_bib0003","doi-asserted-by":"crossref","unstructured":"Jaffe ES, Rosen ST, Greer JP. Pathobiology of peripheral T-cell lymphomas T-Cell Lymphoma. Hematology Am Soc Hematol Educ Program. 2006:317-22. doi:10.1182\/asheducation-2006.1.317. PMID: 17124078.","DOI":"10.1182\/asheducation-2006.1.317"},{"key":"10.1016\/j.clml.2022.04.002_bib0004","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"deLeeuw","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.clml.2022.04.002_bib0006","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II Enteropathy-Associated T-Cell Lymphoma: A Distinct Aggressive Lymphoma With Frequent Gd T-Cell Receptor Expression","volume":"35","author":"Chan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2022.04.002_bib0007","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/pin.12748","article-title":"Monomorphic epitheliotropic intestinal T-cell lymphoma with T-cell receptor (TCR) of silent phenotype shows rearrangement of TCR\u03b2 or TCR\u03b3 gene","volume":"69","author":"Tomita","year":"2019","journal-title":"Pathol Int"},{"key":"10.1016\/j.clml.2022.04.002_bib0008","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.clml.2022.04.002_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2317","article-title":"Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update","volume":"35","author":"Matnani","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2022.04.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068343","article-title":"Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features","volume":"8","author":"Margolskee","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clml.2022.04.002_bib0011","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","article-title":"Recurrent STAT3-JAK2fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","volume":"131","author":"Sharma","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.04.002_bib0012","article-title":"Angioimmunoblastic lymphadenopathy a case with an unusual clinical course with marked tumorous infiltration of multiple organs and striking intestinal involvement","volume":"51","author":"Moreb","year":"1983","journal-title":"AILD"},{"key":"10.1016\/j.clml.2022.04.002_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cgh.2005.10.002","article-title":"Short bowel syndrome and intestinal failure: consensus definitions and overview","volume":"4","author":"O\u2019keefe","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clml.2022.04.002_bib0014","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.iac.2015.04.004","article-title":"Eosinophilia in hematologic disorders","volume":"35","author":"Falchi","year":"2015","journal-title":"Immunol Allerg Clin N Am"},{"key":"10.1016\/j.clml.2022.04.002_bib0015","doi-asserted-by":"crossref","unstructured":"Brito-Babapulle F. The eosinophilias, including the idiopathic hypereosinophilic syndrome.; 2003.","DOI":"10.1046\/j.1365-2141.2003.04195.x"},{"key":"10.1016\/j.clml.2022.04.002_bib0016","first-page":"255","article-title":"The lymphoid variant of hypereosinophilic syndrome study of 21 patients with CD3-CD4+ aberrant T-cell phenotype","volume":"93","author":"Lef\u00e8vre","year":"2014","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.clml.2022.04.002_bib0017","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2169\/internalmedicine.50.5569","article-title":"Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome\/chronic eosinophilic leukemia","volume":"50","author":"Awano","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.clml.2022.04.002_bib0018","first-page":"1086","article-title":"CD3\u2013CD4+ lymphoid variant of hypereosinophilic syndrome: Nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder","volume":"100","author":"Lef\u00e8vre","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2022.04.002_bib0019","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"OrdaI","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2022.04.002_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01765","article-title":"Eosinophilia associated With CD3\u2212CD4+ T cells: characterization and outcome of a single-center cohort of 26 patients","volume":"11","author":"Carpentier","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clml.2022.04.002_bib0021","doi-asserted-by":"crossref","first-page":"285","DOI":"10.6004\/jnccn.2022.0015","article-title":"T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Horwitz","year":"2022","journal-title":"J Natl Compr Cancer Ntwrk"},{"key":"10.1016\/j.clml.2022.04.002_bib0022","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cgh.2013.11.028","article-title":"Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features","volume":"12","author":"Malamut","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clml.2022.04.002_bib0023","unstructured":"Perry AM, Warnke RA, Hu Q, et\u00a0al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract Key Points. doi:10.1182\/blood-2013-07."},{"key":"10.1016\/j.clml.2022.04.002_bib0024","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3960\/jslrt.19022","article-title":"Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy","volume":"60","author":"Takahashi","year":"2020","journal-title":"J Clin Exp Hematopathol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502200115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502200115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:40:02Z","timestamp":1761871202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226502200115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S215226502200115X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2022.04.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}